PubmedID,Title,Publication Date,Non-academic Author(s),Company Affiliation(s),Corresponding Author Email
40624238,IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR,2025,Esther Navarro Manzano; Elena García-Martínez; Francisco Ayala de la Peña,"Centro Regional de Hemodonación, Murcia, Spain.; Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), Murcia, Spain.; Universidad de Murcia, Murcia, Spain.; Universidad Católica San Antonio de Murcia, Guadalupe, Spain.",
40624089,Survival outcomes among patients with breast cancer and leptomeningeal disease.,2025,Veronika Moravan,"Applied Statistician, VM Stats, Toronto, ON, Canada.",
40623688,Characterization of Physical Activity Levels in Female Breast Cancer Survivors: Relationship With Lymphedema (AtiLinf).,2025,Pablo Lobo,"Estudios en Actividad Física (LEAF), Universidad de Flores (UFLO), Ciudad Autónoma de Buenos Aires, Argentina.",
40623673,Comparative Evaluation of Anticancer Activity of Sugar-Rich and Crude Moringa Oleifera Lam. Seed Extracts in MCF-7 and MDA-MB-231 Cells.,2025,Patrycja Adamczuk,"Ecobean, Koszykowa 75,00-662 Warsaw, Poland. Electronic address: p.adamczuk@ecobean.pl.","Ecobean, Koszykowa 75,00-662 Warsaw, Poland. Electronic address: p.adamczuk@ecobean.pl."
40623616,Reopening Pandora's box: is there a role for HDL in breast cancer?,2025,Maria Isabela Alves Caldas Sawada,"Programa de Pós-Graduação em Medicina, Universidade Nove de Julho (UNINOVE), 01525-000, São Paulo, Brazil; Grupo de Saúde de Curitiba (GSAU-CT), Brazilian Air Force, 82510-901 Curitiba, Brazil.",
40623284,Women's Insights on Sexual Health After Breast Cancer (WISH-BREAST) Survey.,2025,Corinne Menn,"Alloy Women's Health, New York, NY.",
40623195,CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitors.,2025,Daniel A Haber,"HHMI, Chevy Chase, MD 20815.",
40622713,"Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.",2025,Melissa C Southey; Rachel A Murphy; Laure Dossus; Bernd Holleczek; Roger L Milne,"Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia.; Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.; Saarland Cancer Registry, Saarbrücken, Germany.",
40622536,A multidisciplinary approach for patients with metastatic breast cancer: a mixed method study.,2025,Viviana Fusetti; Cinzia Brunelli; Giuseppe Capri; Giulia Bianchi; Silvia Lo Dico; Ernesto Zecca; Augusto Caraceni,"Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, Milan, Italy.; Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, Milan, Italy.; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori, Via Venezian 1, Milan, Italy. viviana.fusetti@istitutotumori.mi.it.","Department of Biomedicine and Prevention, Tor Vergata University of Rome, Via Cracovia 50, Rome, Italy. viviana.fusetti@istitutotumori.mi.it."
40621129,Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances.,2025,Doerthe Schaffrin-Nabe; Anke Josten-Nabe; Adrian Heinze; Andrea Tannapfel; Merle Schaffrin; Rudolf Voigtmann,"Ruhr-Universität Bochum, Pathologie, Bochum, 44789, Germany.; Praxis für Hämatologie und Onkologie, Bochum, 44799, Germany.; Noack Statistik GmbH, Bonn, 53119, Germany.",
40621063,BCMA: An integrative and versatile database for multi-scale and multi-omics molecular atlas of breast cancer.,2025,Yonghui Gong; Wenjie Lei,"Hainan Zhongke Data Source Technology Co., Ltd., Hainan, China.",
40620104,Rhabdomyolysis induced by darolutamide and rosuvastatin.,2025,E H Lee; M M Charpentier,"South County Health, Wakefield, RI, USA.",
40619603,Optogenetic-Controlled iPSC-Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in Mice.,2025,Xiang Li; Junwei Zhao,"Beijing Life Science Academy, Beijing, 102209, China.",
40619551,A computational study of cardiac glycosides from Vernonia amygdalina as PI3K inhibitors for targeting HER2 positive breast cancer.,2025,Naufa Hanif,"Doctor of Pharmaceutical Sciences Student, Sekolah Farmasi Institut Teknologi Bandung, ITB Kampus Ganesha. Jl. Ganesa No. 10. Coblong, Kota Bandung, Jawa Barat, 40132, Indonesia.",
40619351,Molecular Mechanisms and Clinical Divergences in HPV-Positive Cervical vs. Oropharyngeal Cancers: A Critical Narrative Review.,2025,Luigi Alfano; Michelino De Laurentiis; Salvatore Cortellino,"Division of Breast Medical Oncology, Istituto Nazionale Tumori -IRCCS-Fondazione G. Pascale, Naples, Italy. m.delaurentiis@istitutotumori.na.it.; SHRO Italia Foundation ETS, Candiolo, Turin, Italy. s.cortellino@ssmeridionale.it.; Cell Biology and Biotherapy Unit, Istituto Nazionale Tumori -IRCCS-Fondazione G. Pascale, Naples, Italy.","Division of Breast Medical Oncology, Istituto Nazionale Tumori -IRCCS-Fondazione G. Pascale, Naples, Italy. m.delaurentiis@istitutotumori.na.it."
40619112,A microsimulation model based on healthcare pathways to estimate the impact of COVID-19 pandemic-induced delays on breast cancer mortality.,2025,J Marghadi,"Service of Medical Information, Gustave Roussy, 114, rue Edouard Vaillant, 94800 Villejuif, France.",
40618953,[Information and screening for sexual disorders of patients with non-metastatic breast cancer: results of a survey].,2025,Auriane Guillier; Florence Dalenc; Sébastien Lamy; Leila Cousseau; Charlotte Vaysse,"Département d'oncologie médicale, Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène-Joliot-Curie, 31059 Toulouse, France.; Département de médecine de la reproduction, CHU de Toulouse, 330 avenue de Grande Bretagne, 31059 Toulouse, France.; Département de chirurgie gynécologique et oncologique, Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène-Joliot-Curie, 31059 Toulouse, France.; Département de gynécologie médicale et obstétrique, CHU de Toulouse, 330 avenue de Grande Bretagne, 31059 Toulouse, France. Electronic address: auriane.guillier@gmail.com.; Département d'épidémiologie, Institut Universitaire du Cancer de Toulouse-Oncopole, 1 avenue Irène-Joliot-Curie, 31059 Toulouse, France.","Département de gynécologie médicale et obstétrique, CHU de Toulouse, 330 avenue de Grande Bretagne, 31059 Toulouse, France. Electronic address: auriane.guillier@gmail.com."
40618899,Selection of patients for proton therapy to reduce risk of second primary lung and breast cancer.,2025,Michiel Kroesen,"HollandPTC, Delft, the Netherlands.",
40618651,Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study.,2025,Amado Rivero; Lilisbeth Perestelo-Pérez,"Canary Islands Research Group (Canary Islands Health Service) Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Tenerife, Spain.; Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain; Canary Islands Foundation for Health Care Research (FUNCANIS), Tenerife, Spain.",
40617755,Best original research presented at the 26th European Congress on Gynaecological Oncology: Best of ESGO 2025.,2025,David Viveros-Carreño,"Cáncer Luis Carlos Sarmiento Angulo (CTIC) and Clínica Universitaria Colombia, Centro de Tratamiento e Investigación sobre Bogotá, Gynecologic Oncologist, Bogotá, Colombia.",
40617721,[Hormone therapy in the adjuvant setting based on risk assessment].,2025,Julie Cabal; Céline Lescure; Véronique Dieras; Fanny Le Du,"CLCC Eugène-Marquis, Rennes, France. Electronic address: f.ledu@rennes.unicancer.fr.; CLCC Eugène-Marquis, Rennes, France.","CLCC Eugène-Marquis, Rennes, France. Electronic address: f.ledu@rennes.unicancer.fr."
40617562,SHIGA TOXINS FROM ENTEROHEMORRHAGIC ESCHERICHIA COLI AND ANTI-GB3 ANTIBODY AS NOVEL AGENTS AGAINST TRIPLE NEGATIVE BREAST CANCER.,2025,Florencia Vassallu; Lionel M Igaz,"CONICET- Universidad de Buenos Aires, Instituto de Fisiología y Biofísica ""Houssay"" (IFIBIO), Grupo de Neurociencia de Sistemas, Buenos Aires, Argentina.",
